Sánchez-Pernaute R, Künig G, del Barrio Alba A, de Yébenes J G, Vontobel P, Leenders K L
Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain.
Neurology. 2000 Jan 11;54(1):119-25. doi: 10.1212/wnl.54.1.119.
Huntington's disease (HD) is generally considered a hyperkinetic disorder, although hypokinetic features are part of the motor syndrome. Moreover, the striatum is considered to play a key role in initiating and executing motor programs and achieving optimal scheduling in response generation. Controversial results regarding the association between clinical features and markers of progression of the disease might be the result of inadequate restriction of clinical signs to the choreatic syndrome.
To determine the relationship of neurologic motor and cognitive indices in patients with HD with intrinsic neuronal loss in the striatum, as measured using raclopride C11 and PET.
A cross-sectional study was performed on 11 patients with mild HD (stages 0-2). Motor (Unified Huntington's Disease Rating Scale [UHDRS], saccadic and tapping speed) and cognitive (verbal fluency, Trail Making Test, Stroop Test, Symbol Digit Modalities Test, Conditioned Associative Learning Test, and silhouette identification and object decision of the Visual Object and Space Perception battery) scores were correlated with raclopride C11 binding.
Bradykinesia (a summation of five items of the UHDRS motor scale) was the best predictor for stage, that is, functional capacity, and showed a highly significant relationship with putaminous D2 binding (r = -0.94) and with CAG expansion length x years of age (r = 0.96). The exclusion of two patients with a rigid-akinetic HD variant did not alter these coefficients. Chorea was less well correlated than bradykinesia with D2 binding in all striatal regions. Performance on different cognitive tests, especially in timed tasks, was highly correlated with raclopride C11 binding in caudate nucleus and ventral striatum.
Loss of D2 binding in the striatum is highly correlated with the deficit in fast motor and cognitive processing in patients with early Huntington's Disease. Thus, impairment of rapid execution of adequate responses to environmental changes seems to be a common manifestation of striatal disorders.
亨廷顿舞蹈症(HD)通常被认为是一种运动机能亢进性疾病,尽管运动机能减退特征也是运动综合征的一部分。此外,纹状体被认为在启动和执行运动程序以及在反应生成中实现最佳调度方面起关键作用。关于疾病临床特征与进展标志物之间关联的有争议结果,可能是由于对舞蹈症综合征临床体征的限制不足所致。
使用雷氯必利C11和PET测量,确定HD患者神经运动和认知指标与纹状体内神经元固有损失之间的关系。
对11例轻度HD(0 - 2期)患者进行了横断面研究。运动(统一亨廷顿舞蹈病评定量表[UHDRS]、扫视和敲击速度)和认知(语言流畅性、连线测验、斯特鲁普测验、符号数字模式测验、条件性联想学习测验以及视觉物体与空间感知电池组的轮廓识别和物体判断)得分与雷氯必利C11结合情况相关。
运动迟缓(UHDRS运动量表五项内容的总和)是分期即功能能力的最佳预测指标,并且与壳核D2结合(r = -0.94)以及CAG重复序列长度×年龄(r = 0.96)显示出高度显著的关系。排除两名患有强直 - 运动不能性HD变异型的患者并未改变这些系数。在所有纹状体区域,舞蹈症与D2结合的相关性不如运动迟缓。不同认知测试的表现,尤其是在限时任务中,与尾状核和腹侧纹状体中的雷氯必利C11结合高度相关。
纹状体中D2结合的丧失与早期亨廷顿舞蹈症患者快速运动和认知处理缺陷高度相关。因此,对环境变化做出充分反应的快速执行受损似乎是纹状体疾病的常见表现。